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Background: Results from several recent cohort studies on smoking and breast cancer incidence and mortality suggest that the
burden of smoking on society is underestimated. We estimated the fraction of breast cancer attributable to smoking in the
Norwegian Women and Cancer Study, a nationally representative prospective cohort study.
Methods: We followed 130 053 women, aged 34–70 years, who completed a baseline questionnaire between 1991 and 2007,
through linkages to national registries through December 2012. We used Cox proportional hazards models to estimate hazard
ratios (HRs) with 95% confidence intervals (CIs), while adjusting for confounders. Never smokers, excluding passive smokers, were
used as the reference group in all main analyses. We estimated attributable fractions (AFs) % in smokers and in the population
(PAFs) % with 95% CIs.
Results: Altogether, 4132 women developed invasive breast cancer, confirmed by histology. Compared with never active, never
passive smokers, ever (former and current) smokers had an overall risk of breast cancer that was 21% higher (HR¼ 1.21; 95%
CI¼ 1.08–1.34). For ever smokers, the AF was 17.3% (95% CI ¼ 7.4–25.4) and for the population the PAF of breast cancer was 11.9%
(95% CI¼ 5.3–18.1). For passive smokers, the PAF of breast cancer was 3.2% (95% CI¼ 1.0–5.4). When we applied PAF estimates for
ever smoking on the 2907 new breast cancer cases among Norwegian women aged 35þ at diagnosis in 2012, this yielded 345
(95% CI¼ 154–526) breast cancer cases that could have been avoided in the absence of active smoking that year.
Conclusions: In smokers, one in six and in the population, one in nine breast cancer cases could have been avoided in the
absence of active smoking. Our findings support the notion that the global cancer burden due to smoking is substantially
underestimated.
Today, there is an international consensus that there is sufficient
evidence to identify mechanisms by which passive and
active cigarette smoking may cause breast cancer (California
Environmental Protection Agency, 2005; Collishaw et al, 2009;
Johnson et al, 2011; International Agency for Research on Cancer,
2012; US Department of Health and Human Services, 2014), but a
disagreement whether the evidence is sufficient (California
Environmental Protection Agency, 2005; Collishaw et al, 2009;
Johnson et al, 2011) or not (International Agency for Research on
Cancer, 2012; US Department of Health and Human Services,
2014) to infer a causal relationship.
However, results from several recent cohort studies, not
included in the above-listed expert reports, on smoking and breast
cancer incidence (Bjerkaas et al, 2013; Gaudet et al, 2013;
Rosenberg et al, 2013; Dossus et al, 2014; Nyante et al, 2014;
Catsburg et al, 2015; Gram et al, 2015) and mortality (Bjerkaas
et al, 2014; Carter et al, 2015) suggest that the burden of smoking
on society is underestimated.
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This was suggested by (Carter et al, 2015) based on the results
from pooled data from five contemporary US cohorts. They show a
substantial portion of excess mortality among current smokers
due to associations with diseases, one being breast cancer, that
have not been formally established as caused by smoking (Carter
et al, 2015).
Findings from the seven above-listed large cohort studies
(Bjerkaas et al, 2013; Gaudet et al, 2013; Rosenberg et al, 2013;
Dossus et al, 2014; Nyante et al, 2014; Catsburg et al, 2015; Gram
et al, 2015), all show a relationship between smoking and breast
cancer that is consistent with causality. Four (Bjerkaas et al, 2013;
Gaudet et al, 2013; Rosenberg et al, 2013; Dossus et al, 2014) were
included in a review from 2014 (Glantz and Johnson, 2014) and in
addition two (Nyante et al, 2014; Catsburg et al, 2015) more of
these studies in a meta-analysis from 2015 (Macacu et al, 2015).
Both reports (Glantz and Johnson, 2014; Macacu et al, 2015)
conclude that both active and passive smoking are associated with
a modest, but real increase in the risk of breast cancer.
Alcohol consumption is an established causal factor for breast
cancer. When the causality between smoking and breast cancer is
discussed, the issue of confounding by alcohol consumption is
usually raised. This has for many years been the main argument for
not having breast cancer established as a smoking-related cancer.
In contradiction to this belief, we found that the smoking-related
risk of breast cancer was neither confounded by alcohol in the
study from the European Prospective Investigation into Cancer
and Nutrition (EPIC) (Dossus et al, 2014), nor in the unique Multi
Ethnic Cohort (Gram et al, 2015).
The International Agency for Research on Cancer estimated
that globally, breast cancer incidences have increased sharply by
more than 20% from 2008 to 2012, when 1.7 million women were
diagnosed with breast cancer (Ferlay et al, 2013). In Norway, there
has been an increase in incidence for both lung and breast cancer
during the last 50 years. In 2012, close to 3000 new breast cancer
cases were diagnosed, of which B20% were in women under the
age of 50 years (Cancer Registry of Norway, 2014).
Among Norwegian women, the prevalence for daily smoking
was 23% in 1954, the peak was at 37% in 1970 and then, the
prevalence of daily smokers stabilised at around 32% for the rest of
the century (Kjønstad et al, 2000). A similar trend has been seen in
Oceanic, European and North American countries, where the
prevalence of smoking among women has significantly decreased
over the past three decades (Eriksen et al, 2015). In 2015, altogether
21% of Norwegian women aged 16–74 years were current (daily or
occasional) smokers (Statistics Norway, 2016).
Worldwide, more women than in the previous generations
initiate smoking in their teens (Giovino et al, 2012; Eriksen et al,
2015). In the study by Bjerkaas et al (2013), comprising more than
300 000 Norwegian women, we found that the mean age at smoking
initiation decreased, and the proportion of women who started to
smoke before their first childbirth increased steadily from 62% for
those born before 1946 to 94% for those born after 1955.
The majority of Norwegian middle-aged women are ever (i.e.,
either former or current) smokers who started as teenagers (Gram
et al, 2005; Helleve et al, 2010; Bjerkaas et al, 2013). We utilised the
Norwegian Women and Cancer Study, a nationally representative
prospective cohort, to estimate the fraction of breast cancer
attributable to passive and ever smoking and the number of breast
cancer cases that could have been avoided in the absence of
smoking in Norway in 2012.
MATERIALS AND METHODS
Study population. The Norwegian Women and Cancer Study
cohort profile has been previously described in detail (Lund et al,
2003; Lund et al, 2008). Briefly, the Central Population Register
selected a random sample of women according to year of birth.
Subsequently, an invitation to participate in the study, with a
baseline questionnaire and a pre-stamped return envelope enclosed
was mailed to each woman. The National Data Inspectorate and
the Regional Committee for Medical Research Ethics approved the
study. All women gave an informed consent https://site.uit.no/
nowac/.
Women who completed a questionnaire during three waves of
data collection: 1991–1992, 1996–1997 and 2003–2007 (172 478)
were included. The overall response rate was 52.7%. We excluded
women with prevalent cancer (7091), who had emigrated (116),
died before start of follow-up (56), who were born after 1957
(3166), who had with missing information on ever (1312) and
passive (5271) smoking status, or on important covariates
(education, height, current weight, menopausal status, parity, age
at first birth and alcohol consumption; 25 413). Altogether, 1248
women with breast cancer were excluded in this process. The
cohort comprised the 130 053 remaining women.
Data collection. At enrolment, the women reported whether they
had ever smoked, the average number of cigarettes smoked per day
at different ages, if they currently smoked daily, and if their parents
smoked during their childhood. Based on the answer to these
questions, we computed age at smoking initiation, and the number
of years smoking. We also calculated pack-years of smoking as the
number of cigarettes smoked per day, divided by 20, and
multiplied by the duration of smoking in years. For parous
smokers, we calculated years of smoking before first childbirth as
the age in years at the birth of the first child minus the age at
smoking initiation.
Outcome assessment. We followed the women through linkages
to the Cancer Registry of Norway and the Norwegian Central
Population Register, to identify all cancer cases, emigrations and
deaths, respectively, using the unique national 11-digit personal
identification number. We calculated person-years from the start
of follow-up to the date of any incident cancer diagnosis (except
basal cell carcinoma), emigration, death or the end of follow-up 31
December 2012, whichever came first. We classified breast cancer
cases according to the original codes in the International
Classification of Diseases, Seventh Revision including estrogen
and progesterone hormone tumour receptor status.
Statistical analysis. For the distribution of selected characteristics
of the study population, we calculated percentages (%) or means
with standard deviations (±s.d.). We estimated crude breast
cancer incidence rates by dividing the number of cases by the total
number of person-years in that exposure (never, passive, former,
current) category (Breslow and Day, 1987). The rates were then
age-adjusted to the world standard population (http://seer.cancer.
gov/stdpopulations/).
We stratified all models by birth cohort and cohort enrolment to
control for calendar and age cohort effects, questionnaire design
and duration of follow-up. We used the Cox proportional hazards
model with age as the underlying time scale, to estimate crude and
multivariate-adjusted hazard ratios (HRs) and 95% confidence
intervals (CIs) for the associations between breast cancer and
different measures of smoking exposure. Smoking exposure was
defined using smoking status at cohort entry (never, passive,
former, current or ever); for women who had ever smoked, further
exposures were defined using age at smoking initiation (o15,
15–19, 20–24, X25 years), smoking duration (p10, 11–20, 21–30,
430 years); and number of pack-years of smoking (p5, 6–10,
11–15, 415). The reference group is never active, never passive
smokers throughout the manuscript, unless otherwise noted. We
determined the associations between different measures of
smoking and breast cancer for the entire study population and
by menopausal and parous status.
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We included covariates, that changed the HR estimate by 5%,
when applicable, that could potentially confound the association
between smoking and breast cancer. We included the following
variables in the final multivariate models; age at enrolment, years
of education (o10, 10–12, 13–16, X17), age at menarche (o13,
13–14, X15), ever oral contraceptives use (yes, no), a variable
including nulliparous and a combination of total number of births
(1, 2, X3) and of age at first childbirth (age o20, 20–24, 25–29,
X30) for a total of 13 categories, family history of breast cancer in
the mother (yes, no), body mass index (calculated from current
height and weight (o20, 20–24.9, 25–29.9, X30 kg m 2)],
menopausal status (yes, no), postmenopausal hormone therapy
use (never, former, current) and average alcohol consumption,
based on the content of pure alcohol in different sorts of beverages
and portion sizes, as grams of alcohol per day (0, 0.1–1.40, 4.1–10,
410)). Women who reported to be teetotalers and those
answering ‘seldom or never’ had their alcohol consumption set
to 0. We did sensitivity analyses for women who were asked about
and had reported on ever attending mammographic screening (yes,
no), 52.5% (76 483).
For parous women, we estimated breast cancer risk by category
of age at smoking initiation in relation to first childbirth (after,
around or within 5 years before first childbirth, or X5 years
before), compared with parous never smokers overall, restricted to
non-drinkers of alcohol and stratified for age (o50; 50þ ), and
tumour hormone receptor status ((estrogen positive and negative),
and (progesterone positive and negative)) at diagnosis. We
estimated breast cancer risk overall according to smoking initiation
in relation to first birth stratified by number of years smoked
(p10, 11–20, 420).
We tested for linear trends across categories of smoking
exposures variables, excluding never smokers, by assigning the
median a score in order to account for the distance between
categories, treating the variable as continuous in the analyses. We
tested for heterogeneity in the association of breast cancer with
smoking status (ever, never) by postmenopausal or parous
(yes, no) status, alcohol abstinence (yes, no), age at diagnosis
o50 (yes, no) and ever attending mammographic screening
(yes, no), using the Wald test.
We calculated the attributable fraction (AF) (%) among passive
and ever smokers and the corresponding population attributable
fraction (PAF) (%) to indicate what proportion of the breast cancer
cases that could have been prevented in smokers and in the
population in the absence of smoking. We used the formula
PAF ¼ PeðRRe1ÞPeRReþð1PeÞ where the notation Pe¼ the proportion of
persons in the population exposed to the risk factor (i.e., passive and
ever smokers) and RRe¼ the relative risk in the exposed compared
with the unexposed group (i.e., passive and ever compared with never
smokers) (World Health Organization, 2012). Likewise, we estimated
the AF (%) and PAF (%) by age at diagnosis o50 years (yes, no). We
calculated the two-sided 95% CIs for the AFs and PAFs using the
PUNAF Stata module (Newson, 2010).
We calculated the number of breast cancer cases attributable to
smoking in women aged 35 years and older using two approaches.
First, we applied the estimated PAF values with the 95% CIs for
passive and ever smoking to the observed number of new breast
cancer cases. Next, we applied the never-smoker age-adjusted
incidence rate of breast cancer in the cohort to the population in
Norway in 2012 and calculated the number of breast cancer cases
expected in the absence of smoking. Then we calculated the
number of breast cancer cases attributable to smoking by
subtracting the expected cases from the number observed (Peto
et al, 1992; Cancer Registry of Norway, 2014). Finally, we estimated
the overall multivariate-adjusted HR with 95% CIs for ever
smokers, compared with a reference group including both never
and passive smokers. We estimated the corresponding PAF (%)
with 95% CIs.
We performed the analyses using SAS, version 9.2 (SAS Institute
Inc., Cary, NC, USA) or in STATA version 12.0 (Stata Corp,
College Statistics, TX, USA) and considered two-sided P-values
o0.05 as statistically significant.
RESULTS
At enrolment, the mean age of the participants was 48.9 (±8.2
s.d.) years. Of these women, 67.5% (n¼ 87 844) reported to be ever
(current 31.9%, former 35.6%) smokers, with mean initiation at age
18.7 (±4.9 s.d.) and 10.2 (±8.9 s.d.) pack-years of smoking.
Among parous women, 62.2% (n¼ 73 356) reported smoking with
a mean duration of 4.9 (±6.5 s.d.) years before their first
childbirth. During the more than 1.7 million person-years of
observation (mean follow-up time was 13.4 (±6.3 s.d.) years, we
ascertained 4132 incident cases of primary invasive breast cancer,
confirmed by histology. Altogether 90.6% (n¼ 117 869) of the
women reported to be alcohol drinkers with a mean alcohol
consumption of 3.5 (±5.1 s.d.) grams per day. The age-
standardised incidence rate for breast cancer among never, passive
and ever smokers was 185.5, 227.5 and 235.3 per 100 000 person-
years, respectively.
Table 1 shows that ever compared with passive and never
smokers were younger at breast cancer diagnosis, at first childbirth
and at menopause; they were less likely to have higher education,
more likely to have used hormonal contraceptives and postmeno-
pausal hormone therapy and to consume alcohol. The alcohol
drinkers were consuming more alcohol (Table 1).
Table 2 shows that compared with never smokers, both the
unadjusted and multivariate adjusted HRs for breast cancer was
increased significantly for passive, former and current smokers.
Compared with the reference group, passive had an overall 18%
higher (HR¼ 1.18; 95% CI¼ 1.05–1.33) and ever (former and
current) smokers a 21% higher (HR¼ 1.21; 95% CI¼ 1.08–1.34)
risk of breast cancer. We found similar HR estimates when we
stratified by menopausal and parous status at entry (Table 2).
The association between ever/never smoking and risk of breast
cancer was neither significantly different for postmenopausal (yes,
no; Wald w2, Pheterogeneity¼ 0.55) nor parous (yes, no; Wald w2,
Pheterogeneity¼ 0.42) status, nor for mammographic screening
attendance (yes, no; Wald w2, Pheterogeneity¼ 0.18). Compared with
a reference group which also included passive smokers, ever
smokers no longer had a statistically significant increased risk for
breast cancer, but achieved one of borderline statistical significance
(HR¼ 1.08; 95% CI¼ 1.00–1.15).
Compared with parous never smokers, ever smokers who had
smoked for 5 or more years before giving birth had a 29% higher
(HR¼ 1.29; 95% CI¼ 1.14–1.46) risk of breast cancer, after
adjustment. For parous ever smokers, significant associations with
breast cancer risk were observed for smoking initiation in relation
to first birth for women overall, for women who did not drink
alcohol, and for women diagnosed before age 50 years (Table 3).
When we used each of the four tumour hormone receptor status
((estrogen positive and negative), and (progesterone positive and
negative)) tumours at diagnosis as an outcome, we found similar
associations with breast cancer risk for smoking initiation in
relation to first birth (data not shown). The association between
ever/never smoking and risk of breast cancer was neither
significantly different for non-drinkers (yes, no; Wald w2,
Pheterogeneity¼ 0.94) nor for age at diagnosis o50 years (yes, no;
Wald w2, Pheterogeneity¼ 0.44).
Figure 1 shows that, after adjustment and stratification by years
of smoking (p10, 11–20, 420), within all three groups, women
who had smoked for 5 or more of these years before the first
childbirth had a more than 20% (HR¼ 1.23; 95% CI¼ 1.07–1.40,
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HR¼ 1.48; 95% CI¼ 1.26–1.73, and HR¼ 1.32; 95% CI¼ 1.07–
1.63) significantly higher risk of breast cancer compared with the
corresponding reference group.
In ever smokers, the AF of breast cancer was 17.3% (95%
CI¼ 7.4–25.4) overall and 25.6% (95% CI¼ 0.76–44.3) for those
diagnosed before age 50 years. Figure 2 shows that the PAF of breast
cancer was 3.2% (95% CI¼ 1.0–5.4) for passive, and 11.9% (95%
CI¼ 5.3–18.1) for ever smoking. For women o50 years at diagnosis,
the PAF of breast cancer was 18.2% (95% CI¼ 0.9–32.5) for ever
smoking. Our PAF estimates for ever smoking applied on the 2907
new breast cancer cases among Norwegian women aged 35þ at
diagnosis in 2012, yielded 345 (95% CI¼ 154–526) breast cancer
cases that could have been avoided in the absence of smoking. The
difference between the expected (n¼ 2 623) and observed (n¼ 2907)
number of breast cancer cases derived from the never-smoker age-
adjusted incidence rate of breast cancer was 284.
Compared with a reference group that also included passive
smokers, ever smokers had an overall risk of breast cancer that was
8% higher (HR¼ 1.08; 95% CI¼ 1.00–1.15). The corresponding
PAF of breast cancer was 4.9% (95% CI¼ 0.2–9.3) for ever
smoking.
DISCUSSION
To our knowledge, the present study is the first to estimate the
fraction of breast cancer attributable to passive and ever smoking
based on a nationally representative prospective cohort study.
We found that in smokers, one in six and in the population, one in
nine breast cancer cases could have been avoided in the absence of
active smoking. These numbers are of a magnitude that can explain
some of the global increase in breast cancer incidence.
A recent publication discussing six factors contributing to
achieving the 25 25 target of non-communicable disease
mortality, does understandably not list breast cancer as one of
the many disease outcomes that will be reduced with declining
tobacco use (Kontis et al, 2014). Globally, in women aged 30–69
years, which is the target age for the 25 25 strategy, breast cancer
is diagnosed in one out of every five female cancer diagnoses
and is the most common form of cancer deaths worldwide (Ferlay
et al, 2013).
As described (California Environmental Protection Agency,
2005; Collishaw et al, 2009; Johnson et al, 2011; International
Agency for Research on Cancer, 2012; US Department of Health
and Human Services, 2014), there is strong support for the
biological plausibility of the association between smoking and
breast cancer that we base our AF and PAF estimates on in the
present study. The possibility that cigarette smoking acts at a
relatively early stage in the carcinogenic process and thereby also
increases the risk of ductal carcinoma in situ of the breast has been
suggested (Kabat et al, 2010), but not confirmed. We use only
invasive breast cancer cases, confirmed by histology, in the present
study.
An important strength of our study is that it is representative of
the Norwegian middle-aged female population, born between 1927
and 1957, both according to exposure and outcome. We know
Table 1. Selected characteristics of women by smoking status at enrolment, Norwegian Women and Cancer Study, 1991–2012
(N¼130 053)
Never smokers Passive smokers
Ever (former and current)
smokers
Characteristics N (%) Mean (±s.d.) N (%) Mean (±s.d.) N (%) Mean (±s.d.)
Women 14 867 (11.4) 27 342 (21.0) 87 844 (67.5)
Age at enrolment 50.7 (8.7) 49.0 (8.2) 48.5 (8.0)
Person-years 200 397 (11.5) 379 082 (21.7) 1 168 105 (66.8)
Follow-up years 13.5 (6.1) 13.9 (6.3) 13.3 (6.3)
Primary invasive breast cancers 411 (9.9) 908 (22.0) 2813 (68.1)
Age at diagnosis 58.9 (7.6) 57.6 (7.6) 56.8 (7.3)
Diagnosis before age 50 years 55 (13.4) 154 (17.0) 522 (18.6)
Premenopausal breast cancer 57 (13.9) 162 (17.8) 519 (18.5)
Family history of breast cancer 818 (5.5) 1476 (5.4) 4568 (5.2)
Higher education X13 years 7909 (53.2) 13 835 (50.6) 34 347 (39.1)
Age at menarche 13.3 (1.4) 13.3 (1.4) 13.3 (1.4)
Age at menopause 49.4 (4.5) 49.1 (4.7) 48.2 (4.9)
Ever hormonal contraceptive use 6452 (43.4) 14 464 (52.9) 54 815 (62.4)
Parous women 13 157 (88.5) 24 799 (90.7) 80 026 (91.1)
Number of children 2.4 (1.4) 2.3 (1.2) 2.1 (1.1)
Age at first childbirth 25.1 (4.3) 24.6 (4.3) 23.6 (4.4)
Postmenopausal 6185 (41.6) 2788 (35.8) 32 151 (36.6)
Ever postmenopausal hormone use 3196 (21.5) 5824 (21.3) 21 961 (25.0)
Non-drinkers 3910 (26.3) 3855 (14.1) 4480 (5.1)
Alcohol consumption (g per day)a 2.0 (3.5) 2.8 (4.0) 4.0 (5.6)
BMI (kg m 2)b 24.3 (3.9) 24.4 (4.0) 24.1 (3.9)
Physical activity scorec 5.8 (1.8) 5.7 (1.8) 5.7 (1.9)
Abbreviation: s.d.¼ standard deviation.
aAmong women who consumed alcohol, expressed in grams per day.
bBody mass index; weight in kilograms divided by the square of the heights in metres.
cPhysical activity score in 10 categories.
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from our previous studies that the smoking exposure (Gram et al,
2009; Gram et al, 2013) and the breast cancer incidence (Lund
et al, 2008) reflect known smoking patterns (Kjønstad et al, 2000;
Helleve et al, 2010) and breast cancer incidence for Norwegian
women (Cancer Registry of Norway, 2014).
We consider it a key strength that, in addition to the main focus
of this paper, we were able to address six (dose response for
different measures of smoking exposures, smoking at an early age
or before first pregnancy, a no active/no passive exposure reference
group, the extent to which the use of alcohol confounds the
association between smoking and risk of breast cancer, the risk
according to menopausal status, and the risk according to estrogen
hormone receptor status) of the seven questions listed in the
Surgeon General’s report (US Department of Health and Human
Table 2. Crude-a and multivariate-b adjusted hazard ratio (HR) estimates for breast cancer with 95% confidence intervals (CIs) for
different measures of smoking exposures overall and stratified by menopausal and parous status, Norwegian Women and
Cancer Study, 1991–2012

































Neverc 411 1 (ref) 1 (ref) 57 1 (ref) 354 1 (ref) 352 1 (ref) 59 1 (ref)
Passive 908 1.19 (1.06–1.33) 1.18 (1.05–1.33) 162 1.33 (0.98–1.81) 746 1.15 (1.01–1.38) 807 1.2 (1.06–1.36) 101 1.15 (0.83–1.59)
Former 1421 1.23 (1.10–1.37) 1.2 (1.07–1.34) 233 1.27 (0.95–1.71) 1188 1.18 (1.04–1.34) 1283 1.24 (1.10–1.40) 138 1.1 (0.81–1.51)
Current 1392 1.22 (1.10–1.36) 1.22 (1.09–1.37) 286 1.33 (0.99–1.79) 1106 1.19 (1.04–1.35) 1243 1.28 (1.13–1.44) 149 1.11 (0.81–1.52)
Ever 2813 1.22 (1.10–1.36) 1.21 (1.08–1.34) 519 1.3 (0.98–1.73) 2294 1.18 (1.05–1.33) 2526 1.26 (1.12–1.41) 287 1.11 (0.83–1.48)
Age at initiation (years)
25þ 177 1.08 (0.91–1.29) 1.08 (0.91–1.30) 14 0.64 (0.36–1.16) 163 1.13 (0.93–1.37) 155 1.11 (0.92–1.34) 22 1.03 (0.63–1.69)
20–24 786 1.26 (1.12–1.42) 1.22 (1.08–1.38) 127 1.36 (0.99–1.87) 659 1.21 (1.05–1.38) 692 1.25 (1.10–1.42) 94 1.22 (0.88–1.71)
15–19 1681 1.21 (1.09–1.35) 1.21 (1.08–1.36) 362 1.36 (1.02–1.83) 1 319 1.16 (1.02–1.32) 1 532 1.27 (1.13–1.44) 149 1.03 (0.75–1.41)
o15 169 1.34 (1.11–1.63) 1.31 (1.07–1.59) 16 0.95 (0.52–1.74) 153 1.35 (1.09–1.67) 147 1.38 (1.12–1.69) 22 1.25 (0.73–2.13)
P-trendd 0.29 0.27 0.026 0.85 0.13 0.8
Smoking duration
0–10 562 1.19 (1.05–1.35) 1.18 (1.04–1.34) 119 1.3 (0.94–1.79) 443 1.16 (1.00–1.34) 518 1.23 (1.07–1.41) 44 0.97(0.66–1.44)
11–20 750 1.21 (1.07–1.37) 1.18 (1.04–1.33) 197 1.3 (0.96–1.76) 553 1.14 (0.99–1.32) 657 1.2 (1.05–1.37) 93 1.25 (0.89–1.75)
21–30 859 1.24 (1.10–1.39) 1.22 (1.08–1.38) 169 1.32 (0.96–1.80) 690 1.19 (1.04–1.37) 776 1.29 (1.13–1.47) 83 1.06 (0.75–1.50)
430 642 1.25 (1.11–1.42) 1.26 (1.10–1.44) 34 1.25 (0.78–1.98) 608 1.24 (1.07–1.42) 575 1.33 (1.15–1.52) 67 1.09 (0.76–1.58)
P-trendd 0.35 0.25 0.87 0.32 0.14 0.87
Number of pack-yearse
0–5 1008 1.15 (1.03–1.30) 1.15 (1.02–1.29) 213 1.29 (0.96–1.75) 795 1.12 (0.98–1.28) 929 1.19 (1.06–1.35) 79 0.96 (0.68–1.36)
6–10 612 1.3 (1.14–1.49) 1.18 (1.04–1.34) 134 1.25 (0.91–1.72) 478 1.15 (0.98–1.28) 551 1.22 (1.07–1.40) 61 1.1 (0.77–1.59)
11–15 519 1.32 (1.16–1.49) 1.31 (1.14–1.49) 103 1.42 (1.01–1.99) 416 1.28 (1.10–1.49) 462 1.37 (1.19–1.58) 57 1.18 (0.81–1.71)
415 674 1.19 (1.05–1.35) 1.29 (1.14–1.47) 69 1.28 (0.88–1.85) 605 1.27 (1.10–1.46) 584 1.35 (1.18–1.55) 90 1.24 (0.89–1.75)
P-trendd 0.004 0.007 0.79 0.012 0.008 0.09
aAdjusted for age.
bAdjusted for age, duration of education, hormone therapy, age at menarche, family history of breast cancer, age at first birth, number of children, hormonal contraceptive use, menopausal
status, alcohol consumption and BMI, all at enrolment.
cNever-active, never-passive smokers as reference group.
dTest for trend excluding never smokers.
eNumber of cigarettes smoked per day multiplied by number of years smoked, divided by 20.
Table 3. Crude-a and multivariate-b adjusted hazard ratio (HR) estimates with 95% confidence intervals (CIs) for breast cancer
among parous women according to smoking initiation in relation to first birth for ever smokers, overall, restricted to non-drinkers












(n¼2877) HRa 95% CI HRb 95% CI
Cases
(n¼189) HRb 95% CI
Cases
(n¼514) HRb 95% CI
Cases
(n¼2363) HRb 95% CI
Neverc 352 1.00 (ref) 1.00 (ref) 84 1.00 (ref) 48 1.00 (ref) 304 1.00 (ref)
Ever, time of smoking
initiation
After first birth 372 1.08 (0.93–1.25) 1.1 (0.95–1.29) 17 0.81 (0.47–1.40) 48 0.97 (0.64–1.49) 324 1.13 (0.96–1.33)
Around or o5 years
before first birth
948 1.16 (1.03–1.32) 1.17 (1.03–1.33) 44 1.16 (0.78–1.72) 184 1.25 (0.89–1.76) 764 1.16 (1.01–1.34)
X5 years before 1205 1.4 (1.24–1.58) 1.29 (1.14–1.46) 44 1.38 (0.95–2.02) 234 1.48 (1.10–1.44) 971 1.26 (1.11–1.45)
P-trendd o0.0001 0.01 0.009 0.01 0.1
aAdjusted for age.
bAdjusted for age, duration of education, hormone therapy, age at menarche, family history of breast cancer, age at first birth, number of children, hormonal contraceptive use, menopausal
status, alcohol consumption when applicable and BMI all at enrolment.
cNever, excluding active and passive, smokers as reference group.
dTest for trend excluding never smokers.
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Services, 2014). Another strength is that, in our analyses, we have
addressed the previously described main concern about confound-
ing by alcohol consumption (International Agency for Research on
Cancer, 2012; US Department of Health and Human Services,
2014). Our results support the notion that the association between
smoking and breast cancer is not confounded by alcohol. We have
previously shown this in both the European cohort study (Dossus
et al, 2014) with close to 10 000 breast cancer cases and in the
US cohort study (Gram et al, 2015) with more than 4000 breast
cancer cases.
Another important contribution of this paper is that our
results show that the increase in risk almost disappear when we
include the passive smokers in the reference group. This finding
helps explain the ‘negative’ or ‘null’ results in most of the older
studies (California Environmental Protection Agency, 2005;
Collishaw et al, 2009; Johnson et al, 2011; International
Agency for Research on Cancer, 2012; US Department of
Health and Human Services, 2014). Also, the corresponding
PAF value decreases from almost 12% to o5% of the breast
cancer cases that could have been avoided in the absence of
smoking.
Other major strengths are the virtually complete follow-up
through the National population-based registries, our ability to
control for potential confounders, the high proportion of ever
smokers, the 30-year lag period between smoking initiation and
time of cohort enrolment for the majority of smokers. We focus
our estimates on ever vs never smokers, which means that the
women do not change smoking status during follow-up. In
Norway, very few women initiate smoking after our enrolment age
of 35 years (Gram et al, 2005; Helleve et al, 2010; Bjerkaas et al,
2013).
We also consider it a strength that we have a high
proportion (i.e., more than 65%), ever smokers. The correspond-
ing figure for the other recently published cohort studies was
59% for the large Norwegian (Bjerkaas et al, 2013) study, 55%
for the US (Nyante et al, 2014) study, around 44% for three
of the studies; the Canadian (Catsburg et al, 2015), the Multi-
Ethnic Cohort (Gram et al, 2015), and the EPIC (Dossus et al,
2014) study, and 37% for the African American (Rosenberg et al,
2013) study.
The main limitation of the present study is the fact that despite



















Figure 1. Multivariatea adjusted hazard ratio estimates with 95% confidence intervals for breast cancer among parous women according to total
(p10, 11–20, 420) years of smoking and smoking initiation in relation to first birth for ever compared with never (excluding passive) parous
smokers, Norwegian Women and Cancer study 1991–2012. B, &, J Smoking initiation after first birth (white shapes). , , Smoking initiation
o5 years before first birth (grey shapes). ~, ’,K Smoking initiation 5 or more years before first birth (black shapes). aCo-variates included in the
multivariate model were age, duration of education, hormone therapy, age at menarche, family history of breast cancer, age at first birth, number























Figure 2. The fraction of breast cancer (%) attributable to passive and active (ever) smoking in middle-aged women in Norway in 2012. The
Norwegian Women and Cancer study 1991–2012. Grey-shaded boxes, women o50 years at diagnosis. Marked boxes, women 50 years or more at
diagnosis. White boxes, all women.
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cases were small for important subset analyses, for example after
stratification for both years of smoking and years of smoking
before first childbirth among parous women. In addition, when we
do separate analyses for women diagnosed before age 50, we get
wide CIs for the PAF estimates due to few cases. Also, we have very
crude estimates for passive smoking and we did not assess lifetime
drinking patterns. We find it difficult to predict what impact more
detailed information on these two variables would have had on our
results. Furthermore, with longer follow-ups the increased breast
cancer risk among ever compared with never smokers may be
concealed or obscured by censoring due to other smoking-related
cancers (Gram et al, 2008, 2009; International Agency for Research
on Cancer, 2012) and competing causes of death (Gram et al,
2013). There may be some residual confounding due to the above-
described factors, or other factors we did not measure. However,
we find it unlikely that these associations should be of a magnitude
that would change our PAF results materially.
In conclusion, our findings support the notion that the global
cancer burden due to smoking is substantially underestimated. Our
results emphasise the need to increase the global effort to stop the
tobacco industry recruiting teenage girls to smoke. Our study
shows that the number of breast cancer cases that may be
prevented worldwide is huge.
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